Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Efficacy and safety of dapagliflozin in patients with ina... | ResearchHub
Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes (DEPICT-1): 24 week results from a multicentre, double-blind, phase 3, randomised controlled trial
0
Authors
Fredrik Thorén
97 more
Fredrik Thorén
•
W. Garvey
95 more
•
Pedro García-Hernández
Published
September 14, 2017
Paper
Conversation
0
Reviews
0
Bounties
0
Sign in to review
Share your thoughts on this paper...
Best
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
The Lancet Diabetes & Endocrinology
Topics
Medicine
Pathology
Internal Medicine
Endocrinology
Surgery
Show all topics
DOI
10.1016/s2213-8587(17)30308-x
Other Formats
PDF
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
The Lancet Diabetes & Endocrinology
Topics
Medicine
Pathology
Internal Medicine
Endocrinology
Surgery
Show all topics
DOI
10.1016/s2213-8587(17)30308-x
Other Formats
PDF
